{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:21:07Z","timestamp":1785928867555,"version":"3.56.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T00:00:00Z","timestamp":1378425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s13318-013-0150-0","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T10:37:26Z","timestamp":1378377446000},"page":"203-210","source":"Crossref","is-referenced-by-count":21,"title":["Solid dispersion tablets of breviscapine with polyvinylpyrrolidone K30 for improved dissolution and bioavailability to commercial breviscapine tablets in beagle dogs"],"prefix":"10.1007","volume":"39","author":[{"given":"Wenjuan","family":"Cong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefeng","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,6]]},"reference":[{"issue":"7","key":"150_CR1","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s12272-010-0706-3","volume":"33","author":"IA Alsarra","year":"2010","unstructured":"Alsarra IA, Alanazi FK, Ahmed SM, Bosela AA, Alhamed SS, Mowafy HA, Neau SH (2010) Comparative study of itraconazole\u2013cyclodextrin inclusion complex and its commercial product. Arch Pharm Res 33(7):1009\u20131017","journal-title":"Arch Pharm Res"},{"key":"150_CR2","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/jps.2600600902","volume":"60","author":"WL Chiou","year":"1971","unstructured":"Chiou WL, Riegelman S (1971) Pharmaceutical applications of solid dispersion systems. J Pharm Sci 60:1281\u20131302","journal-title":"J Pharm Sci"},{"issue":"10","key":"150_CR3","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3109\/03639041003695097","volume":"36","author":"WJ Cong","year":"2010","unstructured":"Cong WJ, Liu QF, Chen X, Gao R, Lu J, Wang YM, Luo GA (2010) Characterization and pharmacokinetics of a novel pirarubicin liposome powder. Drug Dev Ind Pharm 36(10):1186\u20131194","journal-title":"Drug Dev Ind Pharm"},{"key":"150_CR4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0378-5173(01)00891-2","volume":"231","author":"DQM Craig","year":"2002","unstructured":"Craig DQM (2002) The mechanism of drug release from solid dispersion in water-soluble polymers. Int J Pharm 231:131\u2013144","journal-title":"Int J Pharm"},{"key":"150_CR5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/10611860310001615956","volume":"11","author":"TM Goppert","year":"2003","unstructured":"Goppert TM, Muller RH (2003) Plasma protein adsorption of Tween 80- and poloxamer 188-stabilized solid lipid nanoparticles. J Drug Target 11:225\u2013231","journal-title":"J Drug Target"},{"key":"150_CR6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00228-007-0298-0","volume":"63","author":"J He","year":"2007","unstructured":"He J, Bernd T, Zang C, Zhang B, Zhu R, Wang F, Su F, Song J, Tang J, Peng W (2007) Unexpected effect of concomitantly administered curcumin on the pharmacokinetic of talinolol in healthy Chinese volunteers. Eur J Clin Pharmacol 63:663\u2013668","journal-title":"Eur J Clin Pharmacol"},{"key":"150_CR7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijpharm.2011.11.011","volume":"422","author":"MD Hussain","year":"2012","unstructured":"Hussain MD, Saxena V, Brausch JF, Talukder RM (2012) Ibuprofen-phospholipid solid dispersions: improved dissolution and gastric tolerance. Int J Pharm 422:290\u2013294","journal-title":"Int J Pharm"},{"issue":"3","key":"150_CR8","first-page":"209","volume":"67","author":"A Hussein","year":"2012","unstructured":"Hussein A, El-Menshawe S, Afouna M (2012) Enhancement of the in vitro dissolution and in vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of semisolid dispersion using Gelucire 44\/14 as a carrier. Pharmazie 67(3):209\u2013214","journal-title":"Pharmazie"},{"key":"150_CR9","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1021\/la070051a","volume":"23","author":"A Jahn","year":"2007","unstructured":"Jahn A, Vreeland WN, DeVoe DL, Locascio LE, Gaitan M (2007) Microfludic directed formation of liposomes of controlled size. Langmuir 23:6289\u20136293","journal-title":"Langmuir"},{"key":"150_CR10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijpharm.2010.05.023","volume":"395","author":"JH Joe","year":"2010","unstructured":"Joe JH, Lee WM, Park YJ, Joe KH, Oh DH, Seo YG, Woo JS, Yong CS, Choi HG (2010) Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus. Int J Pharm 395:161\u2013166","journal-title":"Int J Pharm"},{"key":"150_CR11","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1021\/js9701465","volume":"86","author":"YF Kaplun","year":"1997","unstructured":"Kaplun YF, Touitou E (1997) Testosterone skin permeation enhancement by menthol through formation of eutectic with drug and interaction with skin lipids. J Pharm Sci 86:1394\u20131399","journal-title":"J Pharm Sci"},{"key":"150_CR12","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.addr.2011.10.009","volume":"64","author":"K Kawakami","year":"2012","unstructured":"Kawakami K (2012) Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drug. Adv Drug Deliver Rev 64:480\u2013495","journal-title":"Adv Drug Deliver Rev"},{"key":"150_CR13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0378-5173(00)00485-3","volume":"205","author":"S Khoo","year":"2000","unstructured":"Khoo S, Porter CJH, Charman WN (2000) The formulation of halofantrine as either non-solubilising PEG 6000 or solubilising lipid based solid dispersions: physical stability and absolute bioavailability assessment. Int J Pharm 205:65\u201378","journal-title":"Int J Pharm"},{"issue":"9","key":"150_CR14","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s12272-011-0908-3","volume":"34","author":"HJ Kim","year":"2011","unstructured":"Kim HJ, Lee SH, Lim EA, Kim JS (2011) Formulation optimization of solid dispersion of mosapride hydrochloride. Arch Pharm Res 34(9):1467\u20131475","journal-title":"Arch Pharm Res"},{"key":"150_CR15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/jps.10566","volume":"93","author":"D Law","year":"2004","unstructured":"Law D, Schmitt EA, Marsh KC, Everitt EA, Wang W, Fort JJ, Krill SL, Qiu Y (2004) Ritonavir\u2014PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations. J Pharm Sci 93:563\u2013570","journal-title":"J Pharm Sci"},{"key":"150_CR16","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.addr.2007.06.016","volume":"59","author":"H Lennern\u00e4s","year":"2007","unstructured":"Lennern\u00e4s H (2007) Animal data: the contributions of the using chamber and perfusion systems to predicting human oral drug delivery in vivo. Adv Drug Deliv Rev 59:1103\u20131120","journal-title":"Adv Drug Deliv Rev"},{"key":"150_CR17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jps.20767","volume":"96","author":"KA Lentz","year":"2007","unstructured":"Lentz KA, Quitko M, Morgan DG, Grace JE, Gleason C, Marathe PH (2007) Development and validation of a preclinical food effect model. J Pharm Sci 96:459\u2013472","journal-title":"J Pharm Sci"},{"key":"150_CR18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0939-6411(00)00076-X","volume":"50","author":"C Leuner","year":"2000","unstructured":"Leuner C, Dressman J (2000) Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 50:47\u201360","journal-title":"Eur J Pharm Biopharm"},{"key":"150_CR19","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.ejmech.2010.01.006","volume":"45","author":"J Lu","year":"2010","unstructured":"Lu J, Cheng CM, Zhao XE, Liu QF, Wang P, Wang YM, Luo GA (2010) PEG-scutellarin prodrugs: synthesis, water solubility and protective effect on cerebral ischemia\/reperfusion injury. Eur J Med Chem 45:1731\u20131738","journal-title":"Eur J Med Chem"},{"key":"150_CR20","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1081\/DDC-100105176","volume":"27","author":"MV Margarit","year":"2001","unstructured":"Margarit MV, Marin MT, Conteras MD (2001) Solubility of solid dispersions of pizotifen malate and povidone. Drug Dev Ind Pharm 27:517\u2013522","journal-title":"Drug Dev Ind Pharm"},{"key":"150_CR21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijpharm.2011.08.041","volume":"420","author":"JJ Moes","year":"2011","unstructured":"Moes JJ, Koolen SLW, Huitema ADR, Schellens JHM, Beijnen JH, Nuijen B (2011) Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001). Int J Pharm 420:244\u2013250","journal-title":"Int J Pharm"},{"issue":"3","key":"150_CR22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s12272-001-1169-6","volume":"31","author":"TA Muhammad","year":"2008","unstructured":"Muhammad TA, Vivian BS (2008) Solid dispersions of dihydroartemisinin in polyvinylpyrrolidone. Arch Pharm Res 31(3):390\u2013398","journal-title":"Arch Pharm Res"},{"key":"150_CR023","doi-asserted-by":"crossref","unstructured":"Narang AS, Srivastava AK (2002) Evaluation of solid dispersions of clofazimine. Drug Dev Ind Pharm 28(8):1001\u20131013","DOI":"10.1081\/DDC-120006431"},{"issue":"27","key":"150_CR23","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1007\/s11095-010-0157-z","volume":"2010","author":"C Tang","year":"2010","unstructured":"Tang C, Prueksaritanont T (2010) Use of in vivo animal models to assess pharmacokinetic drug\u2013drug interactions. Pharm Res 2010(27):1772\u20131787","journal-title":"Pharm Res"},{"key":"150_CR24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0168-3659(00)00209-1","volume":"67","author":"JL Thomas","year":"2000","unstructured":"Thomas JL, Tirrell DA (2000) Polymer-induced leakage of cations from dioleoyl phosphatidylcholine and phosphatidylglycerol liposomes. J Control Release 67:203\u2013209","journal-title":"J Control Release"},{"key":"150_CR25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijpharm.2011.04.065","volume":"414","author":"PHL Tran","year":"2011","unstructured":"Tran PHL, Tran TTD, Park JB, Min DH, Choi HG, Han HK, Rhee YS, Lee DH (2011) Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storage. Int J Pharm 414:48\u201355","journal-title":"Int J Pharm"},{"key":"150_CR26","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/jps.20028","volume":"93","author":"G Verreck","year":"2004","unstructured":"Verreck G, Vandecruys R, De Conde V, Baert L, Peeters J, Brewster ME (2004) The use of three different solid dispersion formulations-melt extrusion, filmcoated beads, and a glass thermoplastic system-to improve the bioavailability of a novel microsomal triglyceride transfer protein inhibitor. J Pharm Sci 93:1217\u20131228","journal-title":"J Pharm Sci"},{"issue":"6","key":"150_CR27","first-page":"525","volume":"67","author":"SX Wan","year":"2012","unstructured":"Wan SX, Sun YQ, Sun L, Tan FP (2012) Chitosan microparticles for oral bioavailability improvement of the hydrophobic drug curcumin. Pharmazie 67(6):525\u2013528","journal-title":"Pharmazie"},{"key":"150_CR28","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/10611860902913380","volume":"17","author":"F Xiong","year":"2009","unstructured":"Xiong F, Xiong C, Ge L, Chen YJ, Wang H, Gu N, Zhu JB (2009) Preparation, characterization, and biodistribution of breviscapine proliposomes in heart. J Drug Target 17:408\u2013414","journal-title":"J Drug Target"},{"key":"150_CR29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijpharm.2011.10.008","volume":"421","author":"F Xiong","year":"2011","unstructured":"Xiong F, Xiong C, Yao J, Chen XM, Gu N (2011) Preparation, characterization and evaluation of breviscapine lipid emulsions coated with monooleate-PEG-COOH. Int J Pharm 421:275\u2013282","journal-title":"Int J Pharm"},{"key":"150_CR30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.molstruc.2011.08.019","volume":"1005","author":"MG Yu","year":"2011","unstructured":"Yu MG, Sun LL, Li W, Lan ZP, Li BB, Tan LQ, Li M, Yang XH (2011) Investigation of structure and dissolution properties of a solid dispersion of lansoprazole in polyvinylpyrrolidone. J Mol Struct 1005:70\u201377","journal-title":"J Mol Struct"},{"issue":"6","key":"150_CR31","first-page":"475","volume":"60","author":"HJ Zhong","year":"2005","unstructured":"Zhong HJ, Deng YJ, Yang BH, Li CL, Du S (2005) Enhanced oral bioavailability of breviscapine after encapsulation in a liposomal formulation. Pharmazie 60(6):475\u2013476","journal-title":"Pharmazie"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-013-0150-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13318-013-0150-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-013-0150-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T11:44:35Z","timestamp":1559475875000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13318-013-0150-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,6]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["150"],"URL":"https:\/\/doi.org\/10.1007\/s13318-013-0150-0","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,6]]}}}